Department of Intensive Care Unit, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.
Department of Radiation Oncology, The Affiliated Suzhou Science & Technology Town Hospital of Nanjing Medical University, Suzhou, China.
Brain Res. 2021 Dec 15;1773:147685. doi: 10.1016/j.brainres.2021.147685. Epub 2021 Oct 9.
The outer mitochondrial membrane protein mitochondrial Rho-GTPase 1 (Miro1) is known to be involved in the regulation of mitochondrial transport required for neuronal protection. Previous reports established that disruption of Miro1-dependent mitochondrial movement could result in nervous system diseases such as Parkinson's disease and Alzheimer's disease. This study was designed to explore the expression and mechanisms of Miro1 in secondary brain injury after traumatic brain injury (TBI). A total of 115 male Sprague Dawley rats were used in the weight-drop TBI rat model, and Miro1 in vivo knockdown was performed 24 h before TBI modeling by treatment with Miro1 short-interfering RNA. Real-time polymerase chain reaction, western blot, immunofluorescence, adenosine triphosphate (ATP) level assay, neuronal apoptosis, brain water content measurement, and neurological score analyses were carried out. Our results showed that the mRNA and protein levels of Miro1 were increased after TBI and co-localized with neurons and astrocytes in the peri-injury cortex. Moreover, Miro1 knockdown further exacerbated neuronal apoptosis, brain edema, and neurological deficits at 48 h after TBI, accompanied by impaired mitochondrial transport, reduction of mitochondria number and energy deficiency. Additionally, the apoptosis-related factors Bax upregulation and Bcl-2 downregulation as Miro1 knockdown after TBI implied that antiapoptotic effects on neuroprotection of Miro1, which were verified by the Fluoro-Jade C (FJC) staining and TUNEL staining. In conclusion, these findings suggest that Miro1 probably plays a neuroprotective role against secondary brain injury through the mitochondria trafficking pathway, suggesting that enhancing Miro1 might be a new strategy for the treatment of TBI.
已知线粒体外膜蛋白线粒体 Rho-GTP 酶 1(Miro1)参与神经元保护所需的线粒体运输的调节。先前的报告表明,破坏 Miro1 依赖性线粒体运动可能导致帕金森病和阿尔茨海默病等神经系统疾病。本研究旨在探讨创伤性脑损伤(TBI)后二次脑损伤中 Miro1 的表达和机制。共使用 115 只雄性 Sprague Dawley 大鼠建立重物跌落 TBI 大鼠模型,在 TBI 模型建立前 24 小时通过 Miro1 短发夹 RNA 处理进行体内 Miro1 敲低。进行实时聚合酶链反应、western blot、免疫荧光、三磷酸腺苷(ATP)水平测定、神经元凋亡、脑水含量测定和神经评分分析。我们的结果表明,TBI 后 Miro1 的 mRNA 和蛋白水平增加,并与损伤周围皮质中的神经元和星形胶质细胞共定位。此外,Miro1 敲低进一步加重了 TBI 后 48 小时的神经元凋亡、脑水肿和神经功能缺损,同时伴有线粒体运输受损、线粒体数量减少和能量不足。此外,Miro1 敲低后凋亡相关因子 Bax 上调和 Bcl-2 下调暗示了 Miro1 对神经保护的抗凋亡作用,这通过氟尿嘧啶 C(FJC)染色和 TUNEL 染色得到了验证。总之,这些发现表明,Miro1 可能通过线粒体运输途径发挥神经保护作用,防止二次脑损伤,这表明增强 Miro1 可能是治疗 TBI 的一种新策略。